Novavax, Inc. (NVAX)
NASDAQ: NVAX · IEX Real-Time Price · USD
12.97
+0.24 (1.89%)
At close: Jul 2, 2024, 4:00 PM
12.90
-0.07 (-0.54%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Novavax Market Cap
Novavax has a market cap or net worth of $1.82 billion as of July 2, 2024. Its market cap has increased by 214.95% in one year.
Market Cap
1.82B
Enterprise Value
1.56B
1-Year Change
214.95%
Ranking
Category
Stock Price
$12.97
Market Cap Chart
Since December 1, 1998, Novavax's market cap has increased from $25.70M to $1.82B, an increase of 6,985.76%. That is a compound annual growth rate of 18.11%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 1.79B | 213.45% |
Dec 29, 2023 | 570.20M | -29.34% |
Dec 30, 2022 | 807.00M | -92.54% |
Dec 31, 2021 | 10.82B | 52.38% |
Dec 31, 2020 | 7.10B | 6,609.55% |
Dec 31, 2019 | 105.80M | -84.98% |
Dec 31, 2018 | 704.40M | 81.13% |
Dec 29, 2017 | 388.90M | 13.78% |
Dec 30, 2016 | 341.80M | -84.90% |
Dec 31, 2015 | 2.26B | 60.10% |
Dec 31, 2014 | 1.41B | 32.47% |
Dec 31, 2013 | 1.07B | 281.83% |
Dec 31, 2012 | 279.60M | 92.96% |
Dec 30, 2011 | 144.90M | -46.33% |
Dec 31, 2010 | 270.00M | 8.56% |
Dec 31, 2009 | 248.70M | 90.28% |
Dec 31, 2008 | 130.70M | -36.71% |
Dec 31, 2007 | 206.50M | -18.35% |
Dec 29, 2006 | 252.90M | 33.74% |
Dec 30, 2005 | 189.10M | 46.70% |
Dec 31, 2004 | 128.90M | -28.82% |
Dec 31, 2003 | 181.10M | 182.53% |
Dec 31, 2002 | 64.10M | -80.46% |
Dec 31, 2001 | 328.10M | 97.53% |
Dec 29, 2000 | 166.10M | 97.03% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
LeMaitre Vascular | 1.85B |
NovoCure | 1.84B |
Kymera Therapeutics | 1.83B |
Catalyst Pharmaceuticals | 1.83B |
Arvinas | 1.82B |
NeoGenomics | 1.77B |
Syndax Pharmaceuticals | 1.74B |
Ardelyx | 1.73B |